HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-04-2007, 10:31 AM   #4
Lala
Senior Member
 
Lala's Avatar
 
Join Date: Feb 2006
Location: South Florida
Posts: 131
Consider the source is what I always say.
Your post contains an article headline form Bloomberg; that is a trade paper and service for those in the financial markets. I can understand the need for articles of this kind. This gives much needed news to shareholders and financial advisors. Bloomberg news is a leader in financial news and usually reports are very accurate. I was excited this morning when my husband called me with the headline news from Bloomberg about Tykerb and Xeloda in brain mets.

While I can certainly understand your position, I personally have a different view. I look at every article on cancer related drugs and every trial as a step forward in this fight against cancer. I have learned it's up to us who live with cancer to educate those that cross our path. I cherish everyday, I am thankful for the drugs I am on. I often think of the ladies that never had the chance to be on Herceptin or Tykerb. I think of all of my stage 4 friends. I miss my friends that has passed; I honor their memory by living to the fullest each day.

This weekend I celebrated Survivors day by painting a tile to be placed on the wall of a new cancer center being built locally.

The words I painted on my tile are the words many live by 'Hope Lives'<O</O
__________________
Lala
DX Fall05 Stage 4 er+ pr+ her2+ liver and bone mets
DX Fall06 Brain mets, Brain mets gone Spring 2007
Lala is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 02:38 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter